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Khalilov, Ilgam, June Hirsch, Rosa Cossart, and Yehezkel
Ben-Ari. Paradoxical anti-epileptic effects of a GluR5 agonist
of kainate receptors. J Neurophysiol 88: 523–527, 2002;
10.1152/jn.00838.2001. Kainate generates in adult hippocampal neu-
rons a seizure but also a massive excitation of interneurons and a
dramatic increase of the inhibitory drive that impinges on principal
cells. This “overinhibition” is largely mediated by GluR5-containing
kainate receptors that are enriched on interneurons. Here, using the
neonatal intact hippocampus in vitro and the triple chamber, we first
show that this mechanism is fully operative in neonatal neurons. We
then report that application to one hippocampus of (RS)-2-amino-3-
(5-tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid—a relatively se-
lective agonist of GluR5 containing kainate receptors—depresses the
propagation of seizure generated in the opposite hippocampus by a
convulsive agent. We conclude that the selective excitation of inter-
neurons by GluR5-containing kainate receptor agonists opens a new
therapeutic approach for the epilepsies.
I N T R O D U C T I O N
Systemic or intracerebral administration of kainate—an ex-
citatory amino acid extracted from sea weeds—generates a
seizure and brain-damage syndrome that mimics several cen-
tral properties of human temporal lobe epilepsy (Ben-Ari 1985;
Nadler 1981). Studies using kainate and kainate analogues in
vivo and in slice preparations have shown that kainate gener-
ates seizures in the CA3 region—by far the most susceptible
brain region to the adverse effect of kainate (Ben-Ari and Gho
1988; Robinson and Deadwyler 1981). These events then prop-
agate to the CA1 region and from there to other limbic struc-
tures leading to the occurrence of recurrent limbic seizures and
a status epilepticus that will propagate to the rest of the cortical
mantle (Ben-Ari and Cossart 2000; Ben-Ari and Gho 1988;
Robinson and Deadwyler 1981). The mechanisms underlying
these effects have been in part elucidated. Kainate activates
high-affinity kainate receptors that are highly expressed on
CA3 pyramidal neurons and their mossy fiber synapses (Gai-
arsa et al. 1994; Monaghan and Cotman 1982; Tremblay et al.
1985), leading to the generation of synchronized bursts via the
recurrent collateral excitatory synapses that interconnect CA3
pyramidal neurons (Miles and Wong 1986; Smith et al. 1995).
Kainate receptors are, however, also enriched on interneu-
rons (Bahn et al. 1994; Bureau et al. 1999; Mulle et al. 1998,
2000; Petralia et al. 1994) and the activation of these receptors
(Cossart et al. 1998; Frerking et al. 1998) produces a massive
excitation of interneurons and a dramatic increase of the tonic
inhibitory drive that impinges on the principal cells. Because of
the important role of GABAergic inhibition in preventing the
generation of seizures, this action is somewhat paradoxical as
it may exert an anti epileptic effect. The aim of the present
study was therefore to examine the functional consequences of
a selective activation of kainate receptors located on interneu-
rons. We relied on the observation that GluR5-containing
kainate receptors are enriched in interneurons (Bahn et al.
1994; Bureau et al. 1999; Mulle et al. 1998, 2000; Petralia et al.
1994) and that their activation by the relatively selective ago-
nist (RS)-2-amino-3-(5-tert-butyl-3-hydroxy-4-isoxazolyl)pro-
pionic acid (ATPA) (Clarke et al. 1997) excites interneurons
and augments the tonic GABAergic inhibition that impinges on
pyramidal neurons (Cossart et al. 1998). We have used the in
vitro intact neonatal hippocampus (Khalilov et al. 1997b) and
a triple chamber that enables the two hippocampi and their
connecting commissures to be in three independent chambers
(Khalilov et al. 1999a). In this chamber, it is possible to apply
a convulsive agent to one hippocampus and test whether a
putative anti-epileptic agent prevents the propagation of the
seizure to the other hippocampus. This enables to avoid pos-
sible interferences between convulsive and anti-epileptic
agents.
M E T H O D S
The intact preparation that we used as well as the triple chamber
have been described elsewhere (Khalilov et al. 1997, 1999). We used
the intact hippocampal formations (IIHFs) of neonatal (P6-P7) Wistar
rats that were placed into a conventional fully submerged chamber
and perfused with ACSF at 30–32°C at a rate of 8–10 ml/min. Whole
cell recordings were performed with patch electrodes with a resistance
of 5–8 M when filled with solutions containing (in mM): 135
K-gluconate, 0.1 CaCl2, 2 MgCl2, 2 Na2ATP, 1 EGTA, and 10
HEPES, pH 7.25, ([ Cl ]in  4.2 mM), pH 7.25, osmolarity, 280
mosm. Tungsten bipolar electrodes disposed in the stratum radiatum
of CA3 area were used to evoke synaptic responses. All neurons were
filled with dyes and reconstructed post hoc for identification.
Group measures are expressed as means  SE, error bars also
indicate SE. Statistical significance of differences was assessed with
the Students t-test, the level of significance was set at P 0.05. Drugs
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used were purchased from Cookson-Tocris [6-cyano-7-nitroquinox-
alene-2,3-dione (CNQX) and 2-amino-5-phosphonovaleric acid (D-
APV)], Sigma (bicuculline, kainate, biocytin), and Alamone (TTX).
ATPA was kindly provided by Lilly (Lilly Research Center).
R E S U L T S
ATPA excites interneurons and inhibits pyramidal neurons in
the neonatal hippocampus
In an earlier study, we had demonstrated that the activation
of GluR5-containing kainate receptors increased GABAergic
inhibition in adult hippocampal slices (Cossart et al. 1998). We
thus first tested whether this effect is also valid in neonatal
neurons. We used P6–P7 intact preparations as the activation
of GABAergic synapses generates at this age primarily a
hyperpolarization (Ben-Ari et al, 1989). Bath application of
ATPA (1 M) produced opposite effects on cell excitability in
simultaneously recorded CA1 interneurons and pyramidal neu-
rons. In cell-attached recordings (Fig. 1, A and B), ATOA (1
M) increased the action potential discharges of interneurons
and reduced that of pyramidal neurons. In whole cell record-
ings at resting membrane potential, ATPA produced a hyper-
polarization of pyramidal neurons (x  7.1  1.1 mV, n  10)
in current-clamp conditions (Fig. 1C) and a dramatic increase
of the frequency of spontaneous inhibitory postsynaptic cur-
rents (sIPSCs; x  1,250.4  201.2%, n  5). Therefore in
neonatal neurons, the activation of GluR5 agonists induces an
increase of the inhibitory drive via a depolarization of inter-
neurons.
ATPA prevents the propagation of seizures from one
hemisphere to the other
To determine the effects of ATPA on the propagation of
epileptiform activities from one hemisphere to the other, field
and patch-clamp recordings were made from both hemi-
spheres. Bath application of high [K]o (7 mM), bicuculline (3
M), or 4-AP (50 M) to one hippocampus generated recur-
rent spontaneous and evoked inter-ictal episodes (Fig. 2).
These are mediated by glutamatergic excitatory postsynaptic
currents and are inward at Vm 45 mV(Fig. 2C). These events
rapidly propagated to the contralateral hippocampus, (Fig. 2D,
FIG. 1. (RS)-2-amino-3-(5-tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid (ATPA) excites interneurones and inhibits pyrami-
dal cells. A: paired recordings in the cell attached configuration from a P6 intact hippocampus in vitro. Note that ATPA produced
a more than 40-fold increase of the frequency of action potentials in the interneuron and an almost full blockade of the discharge
of the pyramidal neuron. B: electrical stimulation generated a barrage of action potentials in a pyramidal neuron. This was fully
blocked by ATPA. C: paired recordings from 2 pyramidal neurons in whole cell configuration current clamp (top) and voltage
clamp (bottom). Note that ATPA produced a hyperpolarization (top) and a massive increase of the frequency of the ongoing
spontaneous inhibitory postsynaptic currents (sIPSCs; bottom). Quantitative data are presented in the right side of the figure.
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mean latency of 25.3  0.8 ms, n  24). Applications of
ATPA (1 M) to the contralateral naı¨ve hippocampus that did
not receive the convulsive agent considerably reduced the
propagation of seizures (Fig. 2C). Thus in most experiments
(65% of the experiments, n  17), it produced a complete
blockade of epileptiform events in the remaining experiments
it reversibly decreased both the amplitude and duration of
inter-ictal events (66.4  1.2 and 75  5.0% of the control
value, respectively, n  6). During the application of ATPA,
GABAergic currents were recorded in the contralateral hip-
pocampus and glutamatergic ones in the treated hippocampus
(Fig. 2C). On wash-out of ATPA, the seizures rapidly propa-
gated to the opposite hippocampus (Fig. 2D). Bath applications
of ATPA after the seizures had been generated in the contralat-
eral hippocampus, similarly blocked the propagated seizures
(not shown).
D I S C U S S I O N
We show that the activation of GluR5-containing kainate
receptors by ATPA prevents the propagation of epileptiform
events from one hemisphere to the other. Although the exact
mechanisms underlying these effects have not been deter-
mined, the powerful excitation of interneurons and the dra-
matic increase of the tonic inhibition that it generates most
likely play an important role. However, ATPA is not entirely
specific for GluR5-containing receptors (Paternain et al. 2000),
and the present results are in disagreement with studies by
Lerma and co-workers that suggest that kainate reduces inhi-
bition in adult neurons (Ben-Ari and Cossart, 2000, 2001;
Lerma 2001; Lerma et al. 2001). Also, the effects of ATPA on
interneurons are reduced but not fully blocked by a selective
KO of GluR5-containing receptors; a double KO of GluR5 and
-6 is required to produce a full blockade of the actions of
ATPA (Mulle et al. 2000). Finally, several interneurons—in
particular in stratum radiatum—are not excited by ATPA (Cos-
sart et al.) suggesting that other mechanisms may be involved
in the actions of kainate. In spite of this, our data are best
explained by a direct excitation of interneurons and a reduction
of the excitability in principal cells. Our observations should
provide a novel approach to reduce the excitability of principal
cells in a cortical network and possibly prevent seizure gener-
ation. The use of the triple chamber provides a unique oppor-
tunity to test these actions without the possible interferences
between the convulsive and anti-epileptic actions of an agent.
Several features of the actions of ATPA, kainate—or other
activators of kainate receptors located on interneurons—are
particularly useful to consider in relation to its suggested
anti-epileptic properties. First, the excitation of CA1 interneu-
rons by these agents is specific because similar applications of
kainate or ATPA do not excite CA1 pyramidal neurons (Cos-
sart et al. 1998). Second, this effect is dramatic and persistent,
it is associated with an 8- to 10-fold increase of the frequency
of GABAergic IPSCs in pyramidal neurons that can persist for
long durations (Cossart et al. 1998; present study). Third, the
FIG. 2. ATPA prevents the propagation of seizures from 1 hemisphere to the other. A: triple chamber preparation, recordings
include both field and whole cell recordings from both hippocampi. B: application of bicuculline (2 M) to 1 hippocampus
generated inter-ictal-like seizures (ILS) that propagated to the contralateral side. C: bicuculline-induced seizures failed to propagate
to the contralateral hemisphere when ATPA (1 M) was present. D: washing out of ATPA enabled the propagation of seizures to
the contralateral hippocampus. Bottom: the same data at a faster display. Quantification of the effects of ATPA is shown in E.
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synaptic input activated by kainate receptors in interneurons is
quite powerful as it readily generates action potentials and
produces an important increase in the excitability of interneu-
rons (Cossart et al. 1998; present study). Nevertheless, it is
important to stress that other actions of ATPA could contribute
to the observed effects. Recent studies suggest that kainate
receptor activation could also reduce glutamate release by a
presynaptic mechanism (Contractor et al. 2000; Frerking et al.
2001). Further studies are required to determine the contribu-
tions of these actions to the anti-epileptic actions of GluR5
agonists.
Our suggestion of paradoxical anti epileptic effects of a
kainate receptor agonist is not incompatible with the epilepto-
genic effects of kainate. Kainate exerts a multitude of actions
on different types of neurons and different channels. The
result—the seizure—is the consequence of these diverse ac-
tions. Thus seizures are generated in the adult hippocampus
primarily because of the activation of the mossy fiber synapses
that are enriched with the GluR6-containing kainate receptors.
Both the knock-out of the GluR6 genes (Mulle et al. 1998) and
the selective lesion of the mossy fibers by neonatal irradiation
prevent the effects of kainate. Also, GABAergic inhibition is
not abolished in epileptic animals; there is rather a reduction of
tonic inhibition restricted to the dendrites of pyramidal neu-
rons—as a result of the degeneration of a subpopulation of
interneurons during the initial status epilepticus. In contrast,
tonic inhibition is increased in the somata of the principal cells
raising the possibility of a paradoxical increase of inhibition in
the epileptic circuit (Cossart et al. 1998, 2001). As interneurons
are capable of high-frequency discharge, we suggest that the
activation by GluR5 agonists of surviving interneurons may in
part replace the missing inhibitory drive. Preliminary experi-
ments suggest that the actions of ATPA are preserved in
neurons recorded in slices obtained from epileptic rats (Hirsch,
unpublished observations).
Further studies are also required to determine the maturation
of the actions of ATPA. Indeed early during development,
GABA provides most of the excitatory drive because of a
different chloride gradient (Ben-Ari 2000; Ben-Ari et al. 1989).
In our studies, ATPA prevented the propagation of seizures
even when GABA generated a depolarization in the recorded
neuron (not shown). This is best explained by the dual excita-
tory and shunting actions of GABA shown in neonatal hip-
pocampal neurons (Khalilov et al. 1999a). Future studies will
also have to compare the maturation of the epileptogenic
actions of kainate (see Khalilov et al. 1999b) to the develop-
ment of the effects of ATPA. Immuno-cytochemical data sug-
gest that interneurons possess GluR5 mRNA already at birth
(Bahn et al. 1994).
In conclusion, our results suggest that the activation of
GluR5-containing kainate receptors can prevent the propaga-
tion of seizure from one hemisphere to the other. Kainate will
generate seizure but at the same time augment the excitatory
input to interneurons and thus lead to an increased inhibition.
The observation that these actions may be mediated by differ-
ent subunits will enable to develop selective drugs that pre-
dominantly act to reduce seizures. The use of the newly de-
veloped triple chamber provides a unique possibility to record
from both hemispheres and determine the effects of various
procedures and agents on the generation and propagation of
activities from one hemisphere to the other.
This work was supported by Institut National de la Sante´ et de la Recherche
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